[Therapeutic form of doxycycline hydrochloride for intravenous administration in the treatment of suppurative-septic diseases].
Efficacy of doxycycline hydrochloride administered intravenously was studied in treatment of severe purulent inflammatory diseases such as pneumonia, lung abscesses, pyothorax, skin and soft tissue infections, peritonitis, purulent cholangitis, etc.. Doxycycline showed significant advantages over tetracyclines: prolonged action, higher efficacy and good tolerance. Favourable results were observed in 85 per cent of the cases.
Pozdniakova
V P
VP
Lobuseva
A N
AN
Bogomolova
N S
NS
Savitskaia
K I
KI
Dutova
E N
EN
Khlebnikov
V P
VP
Blatun
L A
LA
Stepanova
N A
NA
D000293:Adolescent; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D002764:Cholecystitis / Q000188:drug therapy*; D004318:Doxycycline / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D010538:Peritonitis / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013752:Tetracycline / Q000008:administration & dosage
D013752:Tetracycline; D004318:Doxycycline
Lekarstvennaia forma doksitsiklina gidrokhlorida dlia vnutrivennogo vvedeniia pri lechenii gnoĭno-septicheskikh zabolevaniĭ.